MicroTech Medical (Hangzhou) Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
MicroTech Medical (Hangzhou) has a total shareholder equity of CN¥2.0B and total debt of CN¥20.0M, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are CN¥2.2B and CN¥155.4M respectively.
Anahtar bilgiler
1.0%
Borç/özkaynak oranı
CN¥20.01m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | CN¥1.81b |
| Eşitlik | CN¥2.01b |
| Toplam yükümlülükler | CN¥155.39m |
| Toplam varlıklar | CN¥2.17b |
Son finansal sağlık güncellemeleri
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Sep 22
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Jan 18Recent updates
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Sep 22News Flash: One MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235) Analyst Has Been Trimming Their Revenue Forecasts
Jan 20MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Jan 18Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 2235's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥150.8M).
Uzun Vadeli Yükümlülükler: 2235's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥4.6M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 2235 has more cash than its total debt.
Borcun Azaltılması: Insufficient data to determine if 2235's debt to equity ratio has reduced over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: 2235 has sufficient cash runway for more than 3 years based on its current free cash flow.
Tahmini Nakit Akışı: 2235 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 36.9% each year